acetyl-CoA carboxylase inhibitor (Novartis)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Nameacetyl-CoA carboxylase inhibitor (Novartis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetyl-CoA carboxylase 1 inhibitorsAcetyl-CoA carboxylase 2 inhibitors
TargetsAcetyl-CoA carboxylase 1Acetyl-CoA carboxylase 2
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Institutes For Biomedical Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Institutes For Biomedical Research Inc
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A